Literature DB >> 1312046

Platelet-activating factor receptor and signal transduction mechanisms.

S D Shukla1.   

Abstract

Platelet-activating factor (PAF) is the most potent phospholipid agonist known to date. Radioligand binding studies using [3H]PAF and structurally different PAF antagonists have provided the characteristics of PAF receptor(s) and its heterogeneity. Although efforts have been made to isolate the receptor, it was not until the recent cloning of the PAF receptor that the molecular architecture of the receptor can be visualized. The receptor shows homology to the G protein-coupled receptors with seven transmembrane spanning segments. Several serine, threonine, and tyrosine residues are present at the cytoplasmic side, which could serve as sites for phosphorylation. PAF activates GTPase, causes phospholipid turnover via phospholipases C, D, and A2 pathways and also activates protein kinase C and tyrosine kinase. Further, PAF stimulates Ca2+ mobilization some of which may occur via receptor operated channel. Second messengers generated by these multiple signalling pathways play role (or roles) in PAF responses and in the PAF induced expression of primary response genes. These recent developments throw light on the PAF receptor and its signal transduction mechanisms.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1312046     DOI: 10.1096/fasebj.6.6.1312046

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  45 in total

Review 1.  Excitable membranes, lipid messengers, and immediate-early genes. Alteration of signal transduction in neuromodulation and neurotrauma.

Authors:  J P Doucet; N G Bazan
Journal:  Mol Neurobiol       Date:  1992       Impact factor: 5.590

Review 2.  Immunological risk of injectable drug delivery systems.

Authors:  Wim Jiskoot; Rianne M F van Schie; Myrra G Carstens; Huub Schellekens
Journal:  Pharm Res       Date:  2009-02-27       Impact factor: 4.200

3.  Effects of curcumin on the gene expression profile of L-02 cells.

Authors:  Mingjie Zhou; Chunlei Fan; Nan Tian
Journal:  Biomed Rep       Date:  2015-05-04

4.  Effect of locally applied WEB 2086, a platelet-activating factor antagonist, on inflammatory skin conditions in mice.

Authors:  L Kemény; V Trach; A Dobozy
Journal:  Arch Dermatol Res       Date:  1996-07       Impact factor: 3.017

5.  Protective effect of platelet activating factor antagonists on cultured endothelial cell lysis induced by elastase or activated neutrophils.

Authors:  P Renesto; P Vicart; D Paulin; M Chignard
Journal:  Br J Pharmacol       Date:  1996-03       Impact factor: 8.739

6.  Independent regulation of periarteriolar and perivenular nitric oxide mechanisms in the in vivo hamster cheek pouch microvasculature.

Authors:  David D Kim; Takehito Kanetaka; Ricardo G Durán; Fabiola A Sánhez; H Glenn Bohlen; Walter N Durá
Journal:  Microcirculation       Date:  2009-02-23       Impact factor: 2.628

7.  Partial characterization of lipids that develop during the routine storage of blood and prime the neutrophil NADPH oxidase.

Authors:  C C Silliman; K L Clay; G W Thurman; C A Johnson; D R Ambruso
Journal:  J Lab Clin Med       Date:  1994-11

8.  Flow cytometric assay of phagocytic activity of human neutrophils and monocytes in whole blood by neutral red uptake.

Authors:  P Antal; S Sipka; P Surányi; I Csipo; T Seres; L Maródi; G Szegedi
Journal:  Ann Hematol       Date:  1995-05       Impact factor: 3.673

9.  Platelet-activating factor: a candidate human immunodeficiency virus type 1-induced neurotoxin.

Authors:  H A Gelbard; H S Nottet; S Swindells; M Jett; K A Dzenko; P Genis; R White; L Wang; Y B Choi; D Zhang
Journal:  J Virol       Date:  1994-07       Impact factor: 5.103

10.  Involvement of tyrosine kinase and protein kinase C in platelet-activating-factor-induced c-fos gene expression in A-431 cells.

Authors:  Y B Tripathi; R W Lim; S Fernandez-Gallardo; J C Kandala; R V Guntaka; S D Shukla
Journal:  Biochem J       Date:  1992-09-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.